Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 66 out of 100. Getting a diagnosis

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

This Position Paper evaluates the strengths and limitations of the International Working Group research diagnostic criteria and proposes advances to improve the diagnostic framework for Alzheimer's disease. The paper suggests simplifying the diagnosis by requiring an appropriate clinical phenotype alongside a consistent pathophysiological biomarker. Additionally, it proposes that downstream topographical biomarkers may better serve in measuring and monitoring the course of the disease.

What this study adds

Evidence grade: Low

Proposes the IWG-2 research diagnostic criteria for Alzheimer's disease. Criteria set out how the disease is identified for research, which is separate from treating or preventing it.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Dubois, B., Feldman, H., Jacova, C., Hampel, H. J., Molinuevo, J. L., Blennow, K., et al. (2014). Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70090-0

Vancouver

Dubois B, Feldman H, Jacova C, Hampel HJ, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet Neurology. 2014. doi:10.1016/s1474-4422(14)70090-0. PMID: 24849862.

BibTeX

@article{dubois2014-24849862,
  author  = {Dubois, Bruno and Feldman, Howard and Jacova, Claudia and Hampel, Harald Juergen and Molinuevo, José Luís and Blennow, Kaj and DeKosky, Steven T. and Gauthier, Serge G. and others},
  title   = {{Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria}},
  journal = {The Lancet Neurology},
  year    = {2014},
  doi     = {10.1016/s1474-4422(14)70090-0},
  pmid    = {24849862},
  url     = {https://doi.org/10.1016/s1474-4422(14)70090-0}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Why it matters

Proposes the IWG-2 research diagnostic criteria for Alzheimer's disease. Criteria set out how the disease is identified for research, which is separate from treating or preventing it.

Study details

How this study scored 66/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 7 of 7; Citations per year 5 of 5; Impact for its field and year 6 of 6; Cited by studies here 6 of 6; Still being cited 4 of 4; Senior author's track record 4 of 4; Institution's track record 3 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 66 of 100.66 of 100 points earned34 not earned

Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (The Lancet Neurology)
Journal's citation record 3 / 4 The Lancet Neurology: journal h-index 457 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2014 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 7 / 7 Cited 3,319 times (OpenAlex, 2026-10-10)
Citations per year 5 / 5 237.1 citations a year over 14 year(s) since 2014
Impact for its field and year 6 / 6 Cited 185.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 6 / 6 Cited by 202 other studies in this library
Still being cited 4 / 4 Cited 573 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Jeffrey L. Cummings: h-index 175 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 54 institution(s) in 12 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 24849862)
Free to read 2 / 2 Free to read
Total 66 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 91.

Later studies that cite this one

202 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Getting a diagnosis from nearby years

Also in Getting a diagnosis

141 studies in the library are filed under Getting a diagnosis with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Getting a diagnosis hub.

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →